Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
28.53
+1.06 (3.86%)
At close: Mar 9, 2026, 4:00 PM EDT
27.15
-1.38 (-4.84%)
After-hours: Mar 9, 2026, 5:36 PM EDT

Agios Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
1,6721,5871,8741,2451,5431,785
Upgrade
Market Cap Growth
-17.16%-15.30%50.56%-19.32%-13.57%-40.52%
Upgrade
Enterprise Value
547375274448607488
Upgrade
Last Close Price
28.5327.2232.8622.2728.0832.87
Upgrade
PE Ratio
--2.78--1.11
Upgrade
PS Ratio
30.9429.3851.3546.40108.35-
Upgrade
PB Ratio
1.401.331.221.541.401.38
Upgrade
P/TBV Ratio
1.401.331.221.541.401.38
Upgrade
EV/Sales Ratio
10.136.937.5116.7042.61-
Upgrade
Debt / Equity Ratio
0.030.030.040.090.080.08
Upgrade
Net Debt / Equity Ratio
-0.94-0.94-0.96-0.90-0.92-0.92
Upgrade
Net Debt / EBITDA Ratio
2.412.413.511.912.663.22
Upgrade
Net Debt / FCF Ratio
2.982.983.772.473.222.88
Upgrade
Asset Turnover
0.040.040.030.030.01-
Upgrade
Inventory Turnover
11.4311.4313.0821.65--
Upgrade
Quick Ratio
10.5310.5311.0611.4912.5417.17
Upgrade
Current Ratio
11.4611.4611.9012.2713.3017.79
Upgrade
Return on Equity (ROE)
-30.20%-30.20%57.29%-36.83%-19.38%-42.15%
Upgrade
Return on Assets (ROA)
-19.93%-19.93%-20.47%-22.49%-18.17%-20.65%
Upgrade
Return on Invested Capital (ROIC)
-125.09%-87.18%-98.60%-153.69%-100.74%-251.59%
Upgrade
Return on Capital Employed (ROCE)
-38.90%-38.90%-26.90%-45.00%-33.10%-27.50%
Upgrade
Earnings Yield
-24.69%-26.00%35.95%-28.29%-15.02%89.89%
Upgrade
FCF Yield
-22.57%-23.77%-20.89%-23.87%-20.38%-23.14%
Upgrade
Buyback Yield / Dilution
-0.14%-0.14%-4.02%-1.57%9.36%12.39%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.